Your browser doesn't support javascript.
loading
Pharmacokinetics of dolutegravir in HIV-seronegative subjects with severe renal impairment.
Weller, Stephen; Borland, Julie; Chen, Shuguang; Johnson, Mark; Savina, Paul; Wynne, Brian; Wajima, Toshihiro; Peppercorn, Amanda F; Piscitelli, Stephen C.
Affiliation
  • Weller S; GlaxoSmithKline, Research Triangle Park, GlaxoSmithKline, 5 Moore Drive, Research Triangle Park, NC, 27709, USA.
Eur J Clin Pharmacol ; 70(1): 29-35, 2014 Jan.
Article in En | MEDLINE | ID: mdl-24096683
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Integrase Inhibitors / Renal Insufficiency / Heterocyclic Compounds, 3-Ring Type of study: Clinical_trials Limits: Female / Humans / Male / Middle aged Language: En Journal: Eur J Clin Pharmacol Year: 2014 Document type: Article Affiliation country: United States Country of publication: Germany
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Integrase Inhibitors / Renal Insufficiency / Heterocyclic Compounds, 3-Ring Type of study: Clinical_trials Limits: Female / Humans / Male / Middle aged Language: En Journal: Eur J Clin Pharmacol Year: 2014 Document type: Article Affiliation country: United States Country of publication: Germany